Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges.

Animals Apoptosis / physiology Humans Immunotherapy / methods Neoplasms / diet therapy TNF-Related Apoptosis-Inducing Ligand
combination therapy mesenchymal stem/stromal cells nanoparticles resistance tumor necrosis factor-related apoptosis-inducing ligand

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 24 04 2021
accepted: 05 08 2021
entrez: 7 9 2021
pubmed: 8 9 2021
medline: 15 12 2021
Statut: epublish

Résumé

The immune cytokine tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has attracted rapidly evolving attention as a cancer treatment modality because of its competence to selectively eliminate tumor cells without instigating toxicity

Identifiants

DOI: 10.3389/fimmu.2021.699746 PMID: 34489946 PMC: PMC8417882
pubmed: 34489946
doi: 10.3389/fimmu.2021.699746
pmc: PMC8417882
doi:

Substances chimiques

TNF-Related Apoptosis-Inducing Ligand 0

Types de publication

Journal Article Review Retracted Publication

Langues

eng

Sous-ensembles de citation

IM

Pagination

699746

Commentaires et corrections

Type : RetractionIn

Informations de copyright

Copyright © 2021 Razeghian, Suksatan, Sulaiman Rahman, Bokov, Abdelbasset, Hassanzadeh, Marofi, Yazdanifar and Jarahian.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cancer Invest. 2011 Oct;29(8):511-20
pubmed: 21877938
Med Sci Monit. 2017 Oct 26;23:5096-5105
pubmed: 29070784
PLoS One. 2013;8(2):e55922
pubmed: 23431365
Atherosclerosis. 2016 Apr;247:87-96
pubmed: 26878368
Cancer Res. 2008 Dec 1;68(23):9614-23
pubmed: 19047138
Cell Biol Int. 2018 Sep;42(10):1377-1385
pubmed: 29957841
Cell Death Dis. 2018 Aug 29;9(9):875
pubmed: 30158521
Cancer Metastasis Rev. 2018 Dec;37(4):733-748
pubmed: 29541897
Oncol Rep. 2017 Jan;37(1):571-578
pubmed: 28004114
Int J Nanomedicine. 2021 Feb 15;16:1175-1187
pubmed: 33623381
Cell Death Dis. 2017 Dec 12;8(12):3204
pubmed: 29233971
Cytotherapy. 2015 Jul;17(7):885-96
pubmed: 25888191
Tumour Biol. 2016 Aug;37(8):10269-78
pubmed: 26831669
Front Immunol. 2019 Apr 30;10:951
pubmed: 31114586
Biochem Biophys Res Commun. 2020 Dec 10;533(3):289-295
pubmed: 32958259
Neuro Oncol. 2011 Jan;13(1):61-9
pubmed: 21062796
Cancer Res. 2009 May 15;69(10):4134-42
pubmed: 19435900
Biochem Biophys Res Commun. 2006 Dec 29;351(4):1024-30
pubmed: 17097066
Int Immunopharmacol. 2014 Aug;21(2):439-46
pubmed: 24946096
Mol Ther. 2004 May;9(5):666-73
pubmed: 15120327
Oncogene. 2007 Jan 25;26(4):571-82
pubmed: 16909119
Oncoimmunology. 2016 May 04;5(5):e1131380
pubmed: 27467950
Int J Biochem Cell Biol. 2016 Sep;78:327-334
pubmed: 27477310
Lung Cancer. 2013 Dec;82(3):441-8
pubmed: 24148258
Stem Cell Res Ther. 2017 Sep 29;8(1):206
pubmed: 28962646
Int J Oncol. 2016 Jul;49(1):74-88
pubmed: 27176505
Front Mol Biosci. 2021 Mar 10;8:628332
pubmed: 33791337
Exp Cell Res. 2008 Mar 10;314(5):1163-76
pubmed: 18222423
Oncol Rep. 2015 Nov;34(5):2692-8
pubmed: 26352862
Int J Biochem Cell Biol. 2017 Aug;89:147-156
pubmed: 28624529
Int J Pharm. 2020 Jan 5;573:118637
pubmed: 31550511
Anticancer Res. 2020 Dec;40(12):6751-6763
pubmed: 33288568
Int J Pharm. 2018 Oct 5;549(1-2):218-229
pubmed: 30075248
Trends Cancer. 2020 Dec;6(12):989-1001
pubmed: 32718904
Cancers (Basel). 2019 May 11;11(5):
pubmed: 31083589
Oncol Rep. 2020 Sep;44(3):1136-1148
pubmed: 32705218
Int J Mol Sci. 2020 May 29;21(11):
pubmed: 32485960
Carcinogenesis. 2010 Mar;31(3):367-75
pubmed: 19939880
Nat Med. 2001 Aug;7(8):954-60
pubmed: 11479629
PLoS One. 2017 Jan 30;12(1):e0171157
pubmed: 28135339
Sci Rep. 2018 Feb 1;8(1):2182
pubmed: 29391509
Int J Oncol. 2011 Apr;38(4):941-53
pubmed: 21286663
Apoptosis. 2014 Mar;19(3):491-505
pubmed: 24242915
Sci Rep. 2017 Feb 17;7:42748
pubmed: 28209994
Nanotechnology. 2016 May 6;27(18):185101
pubmed: 27001952
Antioxid Redox Signal. 2017 Aug 1;27(4):215-233
pubmed: 27927016
Prostate. 2002 Dec 1;53(4):286-99
pubmed: 12430140
Cell Biosci. 2020 Feb 12;10:15
pubmed: 32082540
EMBO Rep. 2020 Mar 4;21(3):e49254
pubmed: 32009295
iScience. 2019 Feb 22;12:182-193
pubmed: 30690394
Int J Mol Sci. 2008 Jan;9(1):56-64
pubmed: 19325719
Oncogene. 2003 May 15;22(19):2869-81
pubmed: 12771938
Cell Death Dis. 2014 Oct 23;5:e1489
pubmed: 25341043
Br J Cancer. 2005 Apr 25;92(8):1430-41
pubmed: 15846298
Cell Death Differ. 2007 Apr;14(4):851-60
pubmed: 17186022
Arch Biochem Biophys. 2020 Oct 15;692:108539
pubmed: 32777260
Oncotarget. 2016 Sep 20;7(38):61520-61532
pubmed: 27528031
Tumour Biol. 2015 Jun;36(6):4213-21
pubmed: 25586349
J Biol Chem. 2002 Jun 21;277(25):22320-9
pubmed: 11940602
Cancer Gene Ther. 2011 Apr;18(4):229-39
pubmed: 21037557
Theranostics. 2021 Feb 25;11(9):4281-4297
pubmed: 33754061
Oncol Rep. 2015 Mar;33(3):1560-6
pubmed: 25607597
Int J Nanomedicine. 2017 Mar 31;12:2531-2551
pubmed: 28408823
Sci Rep. 2018 Apr 3;8(1):5521
pubmed: 29615720
Cancer Lett. 2008 May 8;263(1):14-25
pubmed: 18329793
Exp Mol Med. 2011 Jan 31;43(1):24-34
pubmed: 21150246
Int J Mol Sci. 2019 Apr 24;20(8):
pubmed: 31022877
Cancer Manag Res. 2019 Jan 22;11:955-968
pubmed: 30774424
Eur J Haematol. 2010 Mar;84(3):212-22
pubmed: 19922463
Acta Biochim Biophys Sin (Shanghai). 2014 Jun;46(6):471-6
pubmed: 24739635
J Surg Res. 2007 Oct;142(2):281-6
pubmed: 17640673
J Mol Signal. 2007 Oct 04;2:10
pubmed: 17916240
Int J Oncol. 2020 Mar;56(3):821-834
pubmed: 32124960
Br J Haematol. 2012 Jun;157(5):586-98
pubmed: 22420897
Apoptosis. 2020 Oct;25(9-10):625-631
pubmed: 32737652
Cancer Lett. 2016 Dec 28;383(2):250-260
pubmed: 27725224
Apoptosis. 2017 Oct;22(10):1205-1224
pubmed: 28702823
Cell Biochem Biophys. 2015 May;72(1):241-9
pubmed: 25524636
Anticancer Res. 2019 Dec;39(12):6635-6643
pubmed: 31810928
J Cell Physiol. 2020 Feb;235(2):1663-1673
pubmed: 31309556
J Biol Chem. 2013 Nov 8;288(45):32343-32356
pubmed: 24078627
Clin Cancer Res. 2001 Feb;7(2):407-14
pubmed: 11234897
J Cell Mol Med. 2008 Dec;12(6B):2628-43
pubmed: 18373740
Mol Cancer Ther. 2003 Jan;2(1):95-103
pubmed: 12533677
Lab Invest. 2003 Jul;83(7):1033-43
pubmed: 12861043
PLoS One. 2010 Apr 19;5(4):e10226
pubmed: 20419107
Int J Mol Sci. 2018 May 13;19(5):
pubmed: 29757258
Cancer Lett. 2019 Jan;440-441:202-210
pubmed: 30393160
Biochem Biophys Res Commun. 2019 Jan 1;508(1):1-8
pubmed: 30409427
Oncol Rep. 2019 Jul;42(1):35-42
pubmed: 31115546
Mol Cancer Ther. 2008 Nov;7(11):3556-65
pubmed: 19001438
Neuro Oncol. 2013 Jan;15(1):29-40
pubmed: 23144078
Mol Cancer. 2007 Oct 22;6:66
pubmed: 17953743
Int J Oncol. 2013 Jul;43(1):329-37
pubmed: 23636231
J Biol Chem. 2009 Apr 24;284(17):11121-33
pubmed: 19261616
Biomed Pharmacother. 2017 May;89:845-856
pubmed: 28282786
Cell Signal. 2014 Mar;26(3):594-602
pubmed: 24308965
Clin Cancer Res. 2017 Jun 15;23(12):2942-2950
pubmed: 27965309
Int J Cancer. 2009 Aug 15;125(4):932-41
pubmed: 19422047
Cell Death Dis. 2015 Feb 26;6:e1666
pubmed: 25719250
Blood. 2018 Jun 21;131(25):2803-2815
pubmed: 29699990
Oncol Lett. 2020 Oct;20(4):72
pubmed: 32863905
Biochem Cell Biol. 2016 Jun;94(3):256-64
pubmed: 27219672
Anticancer Res. 2014 Feb;34(2):729-34
pubmed: 24511006
Clin Cancer Res. 2013 Jan 15;19(2):415-27
pubmed: 23204131
J Biol Chem. 2016 Aug 5;291(32):16925
pubmed: 27496966
J Biol Chem. 2019 Apr 12;294(15):5945-5955
pubmed: 30782845
Mol Cancer Res. 2008 Dec;6(12):1861-71
pubmed: 19074831
Drug Deliv. 2017 Nov;24(1):1526-1536
pubmed: 28994313
Oncoimmunology. 2018 Nov 2;8(2):e1534664
pubmed: 30713790
Clinics (Sao Paulo). 2020;75:e1492
pubmed: 32187278
PLoS One. 2018 Jun 21;13(6):e0198203
pubmed: 29927992
Clin Transl Oncol. 2015 Aug;17(8):657-67
pubmed: 25967100
Anticancer Agents Med Chem. 2019;19(15):1835-1845
pubmed: 31364517
Future Oncol. 2021 Feb;17(5):581-596
pubmed: 33401962
Cancer Biol Ther. 2015;16(8):1194-204
pubmed: 26054751
Thorax. 2014 Jul;69(7):638-47
pubmed: 24567297
J Nat Prod. 2015 Jan 23;78(1):103-10
pubmed: 25537111
Molecules. 2010 Aug 04;15(8):5336-53
pubmed: 20714300
Nanoscale Res Lett. 2013 Apr 09;8(1):161
pubmed: 23570619
Biochem Biophys Res Commun. 2018 Feb 12;496(3):998-1005
pubmed: 29305260
Exp Cell Res. 2017 Nov 15;360(2):226-235
pubmed: 28890292
Sci Rep. 2016 Oct 18;6:35468
pubmed: 27752089
Anticancer Res. 2014 Apr;34(4):1893-9
pubmed: 24692724
Oncotarget. 2015 Apr 30;6(12):9970-84
pubmed: 25991668
Mol Med Rep. 2016 Jul;14(1):263-70
pubmed: 27177228
Toxicol Appl Pharmacol. 2014 Sep 15;279(3):253-265
pubmed: 25034532
Eur J Cancer. 2005 Mar;41(5):786-98
pubmed: 15763656
Cell Death Dis. 2013 Jul 04;4:e702
pubmed: 23828565
Int J Oncol. 2011 Oct;39(4):771-9
pubmed: 21743964
Biomed Pharmacother. 2016 Dec;84:1078-1087
pubmed: 27780136
Oncotarget. 2018 Feb 5;9(17):13451-13461
pubmed: 29568369
Genes Dev. 2002 Jan 1;16(1):33-45
pubmed: 11782443
Cancers (Basel). 2019 Aug 28;11(9):
pubmed: 31466290
Oxid Med Cell Longev. 2019 Mar 25;2019:9675450
pubmed: 31019655
Mol Med Rep. 2019 Feb;19(2):984-993
pubmed: 30569150
FEBS Lett. 2015 Apr 2;589(8):897-903
pubmed: 25747387
Breast Cancer Res Treat. 2008 Feb;107(3):349-57
pubmed: 17453339
Exp Mol Med. 2002 May 31;34(2):114-22
pubmed: 12085986
J Cell Biol. 2010 Mar 22;188(6):851-62
pubmed: 20308427
J Agric Food Chem. 2017 Dec 27;65(51):11179-11191
pubmed: 29164887
Neurol Res. 2020 Dec;42(12):1061-1069
pubmed: 32715947
J Cell Biochem. 2007 Oct 1;102(2):442-52
pubmed: 17393432
Anticancer Res. 2020 Feb;40(2):723-731
pubmed: 32014914
Neurosurgery. 2009 Sep;65(3):610-24; discussion 624
pubmed: 19687708
Evid Based Complement Alternat Med. 2011;2011:535172
pubmed: 19892808
Biochem Biophys Res Commun. 2016 Jun 24;475(2):238-44
pubmed: 27208782
Childs Nerv Syst. 2010 Jul;26(7):897-904
pubmed: 20179950
Mol Carcinog. 2016 Apr;55(4):387-96
pubmed: 25647515
J Biol Chem. 2008 Sep 5;283(36):25003-13
pubmed: 18599488
Biomed Environ Sci. 2017 Jul;30(7):473-481
pubmed: 28756806
Int J Mol Med. 2020 Jul;46(1):280-288
pubmed: 32319535
Blood Cells Mol Dis. 2009 Jan-Feb;42(1):77-84
pubmed: 19038561
Cancer Gene Ther. 2005 Mar;12(3):228-37
pubmed: 15550937
Biotechnol Prog. 2020 Nov;36(6):e3025
pubmed: 32410328
Br J Cancer. 2010 Feb 2;102(3):506-12
pubmed: 20068564
Br J Pharmacol. 2013 Aug;169(8):1723-44
pubmed: 23638798
Cancers (Basel). 2019 Apr 21;11(4):
pubmed: 31010082
Eur J Cancer. 2002 Jan;38(1):167-76
pubmed: 11750847
Neurochem Int. 2009 Nov;55(6):423-30
pubmed: 19409438
Br J Cancer. 2010 Dec 7;103(12):1783-7
pubmed: 21081929
Nat Med. 2002 Mar;8(3):274-81
pubmed: 11875499
Theranostics. 2019 May 9;9(10):2984-2998
pubmed: 31244937
Oncogene. 2021 May;40(18):3201-3216
pubmed: 33767436
Int J Pharm. 2015 Oct 15;494(1):506-15
pubmed: 26315118
Oncogene. 2002 Apr 4;21(15):2283-94
pubmed: 11948412
Ann Oncol. 2012 Nov;23(11):2834-2842
pubmed: 22700995
Nutr Cancer. 2020;72(3):489-494
pubmed: 31306050
J Immunol. 1998 Sep 15;161(6):2833-40
pubmed: 9743343
Front Oncol. 2015 Apr 02;5:69
pubmed: 25883904
Oncotarget. 2014 Jul 15;5(13):4959-71
pubmed: 24970806
Curr Cancer Drug Targets. 2020 Nov 15;:
pubmed: 33200709
Int J Cancer. 2015 Jan 15;136(2):299-309
pubmed: 24866585
Oncogene. 2008 Oct 9;27(46):6012-22
pubmed: 18560353
Int J Mol Sci. 2012 Nov 20;13(11):15343-59
pubmed: 23203129
Cell Rep. 2018 Mar 27;22(13):3385-3392
pubmed: 29590608
Biomaterials. 2020 Mar;233:119753
pubmed: 31923762
Cancer Gene Ther. 2012 Sep;19(9):652-8
pubmed: 22767216
Mol Cell Biochem. 2007 Oct;304(1-2):273-85
pubmed: 17636462
Clin Cancer Res. 2011 May 15;17(10):3233-47
pubmed: 21355080
Ann Oncol. 2016 Apr;27(4):680-7
pubmed: 26802147
Biomed Pharmacother. 2017 Sep;93:948-960
pubmed: 28715876
Endocrine. 2020 Jan;67(1):117-123
pubmed: 31377969
Trends Immunol. 2018 Dec;39(12):1036-1053
pubmed: 30401514
Int J Mol Sci. 2009 Dec 24;11(1):1-13
pubmed: 20161998
Toxicol In Vitro. 2011 Apr;25(3):630-5
pubmed: 21195158
Mol Cancer Ther. 2021 May;20(5):833-845
pubmed: 33632873
PLoS One. 2019 Mar 14;14(3):e0213776
pubmed: 30870485
PLoS One. 2014 Mar 11;9(3):e91558
pubmed: 24618889
Sci Rep. 2018 Nov 30;8(1):17519
pubmed: 30504817
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S716-24
pubmed: 23982257
Int J Biol Sci. 2019 Jan 24;15(3):688-700
pubmed: 30745855
Immunity. 2000 Jun;12(6):611-20
pubmed: 10894161
J Biol Chem. 2007 Oct 12;282(41):29831-46
pubmed: 17698840
Mol Carcinog. 2020 Nov;59(11):1256-1268
pubmed: 32885857
Urol Oncol. 2013 Apr;31(3):331-42
pubmed: 21803611
Exp Dermatol. 2017 Mar;26(3):270-272
pubmed: 27541445
J Biol Chem. 2001 Oct 19;276(42):38361-9
pubmed: 11461904
Br J Cancer. 2010 Nov 23;103(11):1692-7
pubmed: 21063402
Biomed Pharmacother. 2018 Nov;107:1010-1019
pubmed: 30257312
J Cell Physiol. 2018 Oct;233(10):6470-6485
pubmed: 29741767
Food Chem Toxicol. 2019 Apr;126:223-232
pubmed: 30817944
Oncol Rep. 2021 Mar;45(3):869-878
pubmed: 33469674
Anticancer Res. 2011 Nov;31(11):3705-12
pubmed: 22110190
J Exp Med. 1999 Oct 4;190(7):1033-8
pubmed: 10510093
Blood. 1999 Sep 1;94(5):1727-37
pubmed: 10477698
Gene Ther. 2014 Mar;21(3):317-27
pubmed: 24451114
Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):E3355-64
pubmed: 26080425
Cancers (Basel). 2019 May 10;11(5):
pubmed: 31083396
PLoS One. 2011;6(5):e19679
pubmed: 21625476
ACS Nano. 2018 Feb 27;12(2):912-931
pubmed: 29378114
Int J Med Sci. 2019 Sep 20;16(11):1412-1423
pubmed: 31673231
FEBS J. 2019 Feb;286(4):737-749
pubmed: 30552797
Apoptosis. 2007 Aug;12(8):1465-78
pubmed: 17440816
J Cell Physiol. 2019 Aug;234(8):13233-13241
pubmed: 30589076
Apoptosis. 2005 Jan;10(1):233-43
pubmed: 15711939
Infect Agent Cancer. 2017 May 30;12:30
pubmed: 28572836
Blood. 2003 Jul 1;102(1):303-10
pubmed: 12637321
Pharm Res. 2016 Mar;33(3):615-26
pubmed: 26526555
Cancer Res. 2007 Sep 1;67(17):8274-84
pubmed: 17804742
Int J Nanomedicine. 2012;7:1449-60
pubmed: 22619505
Oncotarget. 2017 Oct 9;8(59):100021-100033
pubmed: 29245957
BMC Cancer. 2019 May 24;19(1):496
pubmed: 31126284
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S1011-S1021
pubmed: 30580635
J Biol Chem. 2004 Aug 20;279(34):35829-39
pubmed: 15155747
Clin Cancer Res. 2020 Nov 1;26(21):5759-5771
pubmed: 32669373
J Breast Cancer. 2012 Sep;15(3):273-82
pubmed: 23091539

Auteurs

Ehsan Razeghian (E)

Human Genetics Division, Medical Biotechnology Department, National Institute of Genetics Engineering and Biotechnology (NIGEB), Tehran, Iran.

Wanich Suksatan (W)

Faculty of Nursing, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand.

Heshu Sulaiman Rahman (H)

Department of Physiology, College of Medicine, University of Suleimanyah, Suleimanyah, Iraq.
Department of Medical Laboratory Sciences, Komar University of Science and Technology, Sulaimaniyah, Iraq.

Dmitry O Bokov (DO)

Institute of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russia.
Laboratory of Food Chemistry, Federal Research Center of Nutrition, Biotechnology and Food Safety, Moscow, Russia.

Walid Kamal Abdelbasset (WK)

Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia.
Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt.

Ali Hassanzadeh (A)

Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Faroogh Marofi (F)

Immunology Research Center (IRC), Tabriz University of Medical Sciences, Tabriz, Iran.

Mahboubeh Yazdanifar (M)

Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States.

Mostafa Jarahian (M)

Toxicology and Chemotherapy Unit (G401), German Cancer Research Center, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Harnessing TRAIL-Induced Apoptosis Pathway for...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Mort cellulaire › Mort cellulaire régulée › Apoptose › Harnessing TRAIL-Induced Apoptosis Pathway for...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Harnessing TRAIL-Induced Apoptosis Pathway for...
questionsmedicales.fr › Thérapeutique › Biothérapie › Immunothérapie › Harnessing TRAIL-Induced Apoptosis Pathway for...
questionsmedicales.fr › Tumeurs › Harnessing TRAIL-Induced Apoptosis Pathway for...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Facteurs de nécrose tumorale › Ligand TRAIL › Harnessing TRAIL-Induced Apoptosis Pathway for...